This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: developing nanodevices that will remove the clot ahead of time and save lives. If a patient has a clot surgically removed without nanodevices, there is a 30% to 50% chance of a “relapse”, where the clot forms again. These nanodevices can proactively target future potential threats. Nanotechnology does not only provide a means for aiding patients, but it also provides scientists with more information regarding the heart. By creating nanoscopic probes, scientists are able to learn a great deal more about cardiovascular health. http://www.sciencedirect.com/science? _ob=ArticleURL&_udi=B7MDB-4NC62JR-3&_user=918210&_coverDate=03%2F31%2F2007&_rdoc=3&_fmt=full& _orig=browse&_srch=doc-info(%23toc %2323226%232007%23999969998%23647492%23FLA%23display %23Volume)&_cdi=23226&_sort=d&_docanchor=&_ct=11&_acct=C000 047944&_version=1&_urlVersion=0&_userid=918210&md5=c06215fe a1de3014f92ec182118e9880#secx12...
View Full Document
- Spring '07
- Nanotechnology, Nanodevices, Travis Norrell GEEN, future potential threats